ReviewFrontiers of medicine2016
Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns.
Review in Frontiers of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- Cross-sectional study of Middle East respiratory syndrome coronavirus in humans and dromedary camels in Diyala, Iraq.Turkish journal of medical sciences · 2022Article
- Risk management and infection control preparedness of Saudi healthcare facilities to overcome the COVID-19 pandemic.IJID regions · 2022Article
- Expression, purification, and biophysical characterization of recombinant MERS-CoV main (MInternational journal of biological macromolecules · 2022Article
- The first clusters of Middle East respiratory syndrome coronavirus in Oman: Time to act.Journal of infection and public health · 2020Review
- Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia.Frontiers of medicine · 2019Article
- Working experiences of nurses during the Middle East respiratory syndrome outbreak.International journal of nursing practice · 2018Article
- Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk.Transfusion medicine reviews · 2017Review
- MERS-CoV papain-like protease (PL3 Biotech · 2017Article
- Middle East Respiratory Syndrome.The New England journal of medicine · 2017Article
- Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.BMC infectious diseases · 2017Article
- Association between Australian Hajj Pilgrims' awareness of MERS-CoV, and their compliance with preventive measures and exposure to camels.Journal of travel medicine · 2016Article
- Knowledge and Attitude of Dental Health Professionals about Middle East Respiratory Syndrome in Saudi Arabia.Journal of International Society of Preventive & Community DentistryArticle
- Knowledge and awareness of Middle East respiratory syndrome coronavirus among Saudi and Non-Saudi Arabian pilgrims.International journal of health sciencesArticle
- Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia.Travel medicine and infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 brought back memories of the occurrence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002. More than 1500 MERS-CoV cases were recorded in 42 months with a case fatality rate (CFR) of 40%. Meanwhile, 8000 cases of SARS-CoV were confirmed in six months with a CFR of 10%. The clinical presentation of MERS-CoV ranges from mild and non-specific presentation to progressive and severe pneumonia. No predictive signs or symptoms exist to differentiate MERS-CoV from community-acquired pneumonia in hospitalized patients. An apparent heterogeneity was observed in transmission. Most MERS-CoV cases were secondary to large outbreaks in healthcare settings. These cases were secondary to community-acquired cases, which may also cause family outbreaks. Travel-associated MERS infection remains low. However, the virus exhibited a clear tendency to cause large outbreaks outside the Arabian Peninsula as exemplified by the outbreak in the Republic of Korea. In this review, we summarize the current knowledge about MERS-CoV and highlight travel-related issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.